Submission Details
| 510(k) Number | K223231 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 18, 2022 |
| Decision Date | February 24, 2023 |
| Days to Decision | 129 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K223231 is an FDA 510(k) clearance for the Ti-Largo Cervical Interbody System, a Intervertebral Fusion Device With Bone Graft, Cervical (Class II — Special Controls, product code ODP), submitted by Flospine (Boca Raton, US). The FDA issued a Cleared decision on February 24, 2023, 129 days after receiving the submission on October 18, 2022. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3080.
| 510(k) Number | K223231 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 18, 2022 |
| Decision Date | February 24, 2023 |
| Days to Decision | 129 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | ODP — Intervertebral Fusion Device With Bone Graft, Cervical |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3080 |
| Definition | Intended To Stabilize Cervical Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft. |